The evolving regulatory landscape and intensified focus on supplier qualifications present opportunities to enhance compliance and quality management. This course offers strategies for navigating ...

Andrew Chang and Steven Falcone, Novo Nordisk, discuss GMP mutual recognition, real-time digital monitoring, and the future ...

The Spring release advances Blue Mountain’s mission to deliver the most purpose-built EAM platform for regulated manufacturing by helping life sciences organizations reduce manual processes, ...

Market opportunities include enhancing medical device quality through robust process validation training, aligning with regulatory and QMS needs, and integrating GAMPv for improved data integrity.

HARd is HYTN’s proprietary remediation process for dried cannabis flower, developed and validated within the Company’s GMP quality systems. The process is designed to reduce microbial burden while ...

HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) ("HYTN" or the "Company"), a pharmaceutical manufacturer specializing in ...

New biologics facilities and expansions by leading CDMOs are supporting strong replacement and greenfield demand, especially in Asia-Pacific. Key trends include supply chain diversification, ...

Understand cGMP requirements for portable environmental monitoring to support contamination control in pharmaceutical cleanrooms.

Please replace the release with the following corrected version due to multiple revisions.The updated release reads:MOUNTAIN VALLEY MD ANNOUNCES APPOINTMENT OF ADVISORS AND STOCK OPTION GRANTSMountain ...

Mountain Valley MD Holdings Inc. (the " Company " or " MVMD ") (CSE: MVMD) (OTC: MVMDF) is pleased to announce the appointment of multiple advisors to the Company as well as the grant of stock options ...

CHICAGO, IL / ACCESS Newswire / April 16, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the ...

Listing on the OTCQB allows us to more effectively engage with U.S. investors as we build a larger, more diversified life sciences platform,” said Craig Milne, Chief Executive Officer of Innovotech ...